Cryoport, Inc. (CYRX) News
Track canonical SquawkNews coverage tagged to CYRX, Cryoport, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 2 indexed stories across 2 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
Conference Call: CryoPort Affirms FY2026 Sales Guidance of $192.000M-$196.000M vs $194.390M Est
CryoPort (NASDAQ: CYRX ) affirms FY2026 sales outlook from $192.000 million-$196.000 million to $192.000 million-$196.000 million vs $194.390 million estimate.
EARNINGS | Aug 06, 2026, 10:21 PM UTC
L
CYRX Partners Verismo
Cryoport's IntegriCell cryopreservation services are selected by Verismo Therapeutics to support clinical KIR-CAR T cell therapy programs
EQUITY | Jun 25, 2026, 12:01 PM UTC